HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xue Zhang Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

3/2023Lamprey prohibitin 2 inhibits non-small cell lung carcinoma cell proliferation by down-regulating the expression and phosphorylation levels of cell cycle-associated proteins.
11/2022Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non-small cell lung cancer.
11/2022Immunotherapy combined with chemotherapy versus chemotherapy alone as the first-line treatment of PD-L1-negative and driver-gene-negative advanced nonsquamous non-small-cell lung cancer: An updated systematic review and meta-analysis.
1/2022What Is Long-Term Survival and Which First-Line Immunotherapy Brings Long-Term Survival for Advanced Wild-Type Non-Small Cell Lung Cancer: A Network Meta-Analysis Based on Integrated Analysis.
1/2022Case Report: An "Immune-Cold" EGFR Mutant NSCLC With Strong PD-L1 Expression Shows Resistance to Chemo-Immunotherapy.
1/2022Combined Lorlatinib, Dabrafenib, and Trametinib Treatment for ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer with a Lorlatinib-Induced BRAF V600E Mutation: A Case Report.
1/2021Selection of optimal first-line immuno-related therapy based on specific pathological characteristics for patients with advanced driver-gene wild-type non-small cell lung cancer: a systematic review and network meta-analysis.
1/2021The Prognostic Value of Baseline Distant Metastasis in Icotinib-Treated Patients with EGFR-Mutated Stage IV Non-Small Cell Lung Cancer.
1/2021Weighting tumor-specific TCR repertoires as a classifier to stratify the immunotherapy delivery in non-small cell lung cancers.
1/2021Comparison of Efficacy and Safety of Single and Double Immune Checkpoint Inhibitor-Based First-Line Treatments for Advanced Driver-Gene Wild-Type Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xue Zhang Research Topics

Disease

231Neoplasms (Cancer)
05/2024 - 06/2002
65Inflammation (Inflammations)
03/2024 - 07/2010
48Infections
05/2024 - 05/2007
40Neoplasm Metastasis (Metastasis)
03/2024 - 08/2004
28Hepatocellular Carcinoma (Hepatoma)
06/2024 - 05/2016
26Lung Neoplasms (Lung Cancer)
03/2024 - 01/2017
24Pain (Aches)
01/2024 - 05/2010
22Carcinogenesis
06/2024 - 03/2004
22Stomach Neoplasms (Stomach Cancer)
04/2024 - 05/2002
21Breast Neoplasms (Breast Cancer)
01/2023 - 01/2013
20Asthma (Bronchial Asthma)
01/2023 - 11/2014
16COVID-19
02/2024 - 01/2020
16Hypoxia (Hypoxemia)
05/2023 - 06/2006
16Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2023 - 01/2018
15Colorectal Neoplasms (Colorectal Cancer)
02/2024 - 09/2007
14Pneumonia (Pneumonitis)
11/2023 - 09/2012
13Chronic Obstructive Pulmonary Disease (COPD)
11/2022 - 09/2012
12Parkinson Disease (Parkinson's Disease)
08/2023 - 11/2006
11Neuroinflammatory Diseases
05/2024 - 01/2014
11Stroke (Strokes)
05/2024 - 11/2010
11Wounds and Injuries (Trauma)
05/2024 - 12/2016
11Postoperative Pain
04/2024 - 10/2011
11Adenocarcinoma of Lung
03/2024 - 01/2018
11Alzheimer Disease (Alzheimer's Disease)
08/2023 - 12/2005
11Fibrosis (Cirrhosis)
06/2023 - 01/2017
11Hypertension (High Blood Pressure)
10/2022 - 08/2014
10Sepsis (Septicemia)
12/2024 - 10/2021
10Obesity
04/2024 - 04/2011
10Carcinoma (Carcinomatosis)
12/2023 - 12/2003
10Glioma (Gliomas)
01/2023 - 01/2014
10IGA Glomerulonephritis (IGA Nephropathy)
10/2022 - 10/2019
9Atherosclerosis
01/2024 - 01/2014
9Liver Neoplasms (Liver Cancer)
08/2023 - 06/2017
9Neurodegenerative Diseases (Neurodegenerative Disease)
11/2022 - 07/2006
9Cardiovascular Diseases (Cardiovascular Disease)
04/2021 - 01/2012
8Cognitive Dysfunction
01/2024 - 10/2020
8Lung Injury
11/2023 - 12/2016
8Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2021 - 06/2012
7Ischemic Stroke
05/2024 - 03/2009
7Necrosis
05/2024 - 09/2009
7Cardiomyopathies (Cardiomyopathy)
03/2024 - 07/2015
7Insulin Resistance
03/2024 - 11/2012
7Hemorrhage
02/2024 - 01/2016
7Proteinuria
07/2023 - 10/2019

Drug/Important Bio-Agent (IBA)

83Proteins (Proteins, Gene)FDA Link
04/2024 - 03/2004
47Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2011
31DNA (Deoxyribonucleic Acid)IBA
05/2024 - 05/2002
29CytokinesIBA
06/2024 - 06/2007
26Messenger RNA (mRNA)IBA
01/2023 - 08/2004
21RNA (Ribonucleic Acid)IBA
04/2024 - 04/2004
20Therapeutic UsesIBA
02/2024 - 05/2010
20EnzymesIBA
01/2024 - 09/2012
19MicroRNAs (MicroRNA)IBA
11/2023 - 01/2011
16AntigensIBA
03/2024 - 08/2007
15Glucose (Dextrose)FDA LinkGeneric
12/2024 - 04/2011
15LipidsIBA
05/2024 - 01/2013
14Interleukin-6 (Interleukin 6)IBA
04/2024 - 12/2012
12Small Interfering RNA (siRNA)IBA
02/2024 - 09/2005
12Phosphotransferases (Kinase)IBA
11/2023 - 10/2016
12Opioid Analgesics (Opioids)IBA
12/2022 - 05/2012
11CholesterolIBA
03/2024 - 01/2014
11LipopolysaccharidesIBA
12/2023 - 03/2015
11Immune Checkpoint InhibitorsIBA
06/2023 - 06/2018
10celastrolIBA
03/2024 - 03/2014
10Peptides (Polypeptides)IBA
12/2023 - 12/2005
9InflammasomesIBA
04/2024 - 10/2016
9Analgesics (Analgesic Drugs)IBA
04/2024 - 02/2011
9LigandsIBA
03/2024 - 05/2015
9Apolipoproteins E (ApoE)IBA
03/2024 - 01/2014
9AntibodiesIBA
02/2024 - 07/2006
9Transcription Factors (Transcription Factor)IBA
11/2023 - 10/2014
9GlucocorticoidsIBA
01/2023 - 01/2017
9Long Noncoding RNAIBA
01/2023 - 04/2015
9CateninsIBA
12/2022 - 02/2016
9OzoneIBA
11/2022 - 01/2017
8AutoantibodiesIBA
03/2024 - 01/2021
8Glycoproteins (Glycoprotein)IBA
12/2023 - 01/2015
8Liposomes (Liposome)IBA
12/2023 - 01/2017
8Immunoglobulin A (IgA)IBA
02/2023 - 02/2020
8Insulin (Novolin)FDA Link
11/2022 - 04/2014
8Interleukin-17 (Interleukin 17)IBA
01/2022 - 11/2014
8galactosyl-deficient IgA1IBA
01/2022 - 10/2019
7VaccinesIBA
02/2024 - 07/2007
7Adrenal Cortex Hormones (Corticosteroids)IBA
02/2024 - 01/2017
7Reactive Oxygen Species (Oxygen Radicals)IBA
01/2024 - 01/2017
7Anti-Bacterial Agents (Antibiotics)IBA
12/2023 - 07/2013
7Immunoglobulin G (IgG)IBA
07/2023 - 05/2017
7Morphine (MS Contin)FDA LinkGeneric
12/2022 - 05/2012
7CollagenIBA
01/2021 - 01/2017

Therapy/Procedure

92Therapeutics
03/2024 - 11/2004
25Immunotherapy
01/2024 - 01/2017
24Drug Therapy (Chemotherapy)
02/2024 - 05/2015
14Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2024 - 09/2011
13Photothermal Therapy
01/2023 - 04/2014
11Precision Medicine
01/2023 - 06/2017
9Ligation
01/2024 - 03/2009
9Lasers (Laser)
12/2019 - 11/2004
8Anesthesia
04/2024 - 05/2012
8Length of Stay
02/2024 - 01/2016
8Radiotherapy
05/2023 - 01/2017